Orthofix reports Q2 EPS (36c) vs. (88c) last year

Reports Q2 revenue $203.12M, consensus $197.11M. “Orthofix’s (OFIX) second quarter results demonstrate clear progress on our three-year plan to transform the business,” said Massimo Calafiore, president and CEO. “Our disciplined approach led to strong adjusted EBITDA margin growth and positive free cash flow generation, underscoring our ability to grow the business responsibly. Strategic initiatives, like accelerating distributor transitions in certain underpenetrated U.S. territories, are gaining traction and creating a powerful foundation for a more scalable commercial organization to drive our next phase of growth. Looking ahead, we expect to benefit from our recent product launches and deliver meaningful product innovation to improve outcomes and efficiencies for our surgeons and their patients. I am confident the Company is well positioned to deliver sustainable, long-term shareholder value throughout the second half of 2025 and beyond.”